Recent Updates
Recently added Catalysts
PODD Positive Sentiment

Insulet Announces Omnipod Discover Now Available in U.S.

Monday, October 12, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Insulet Corporation has announced the full market release of Omnipod Discover in the U.S. This innovative web-based data platform is designed for users of the Omnipod 5 insulin pump, providing critical diabetes data visualizations and personalized insights. The platform aims to enhance collaboration between users and healthcare providers.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new web-based data platform for diabetes management.
  • Enhances understanding of diabetes data for users and healthcare providers.
  • Supports personalized insights for better diabetes care.

Full Press Release Details

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the U.S. full market release of Omnipod Discover™, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs). Omnipod Discover turns critical diabetes data into clear visualizations and personalized insights, giving people with diabetes and their HCPs a shared understanding of

Frequently Asked Questions

What is Omnipod Discover?

Omnipod Discover is a web-based data platform designed for Omnipod 5 users.

Who can use Omnipod Discover?

It is designed for Omnipod 5 users, their caregivers, and healthcare providers.

What benefits does Omnipod Discover offer?

It provides critical diabetes data visualizations and personalized insights.

When was Omnipod Discover released in the U.S.?

Insulet announced its full market release today.

ShareAdd on Google
Tags: PODD Insulet Omnipod diabetes management healthcare providers data platform
Last updated: Oct 12, 2026

Biotech snapshot

Cash runway
$535M liquidity · $0M/mo burn
Low dilution risk